• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Supplemental oxygen does not reduce mortality in stroke patients

bySusy LamandMichael Milligan
September 29, 2017
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Neurology, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. This randomized clinical trial showed that among patients with acute stroke, supplementary low-dose oxygen for 72 hours (either nocturnal or continuous) did not reduce death or disability at 3 months compared to control.

2. There were no significant differences in adverse events between treatment groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Hypoxia is common during the first few days after an acute stroke and is associated with high rates of neurological deterioration and death. There is evidence showing that continuous monitoring of oxygen saturation post-stroke is associated with better outcomes, but hypoxia is not always identified and treated despite rigorous monitoring. Supplemental oxygen could prevent hypoxia and repercussions of hypoxic brain damage, but can also have adverse effects. The aim of the Stroke Oxygen Study is to determine whether low dose oxygen therapy during the first 3 days after an acute stroke can improve mortality and disability. This randomized control study found that the groups who received either continuous or nocturnal supplemental oxygen experienced no significant decreases in mortality or disability compared to the control group, who received no routine oxygen. There were also no significant differences in the proportion of adverse events reported between the three groups.

There are a few limitations to the study. Firstly, minor benefits from oxygen treatment may have been masked by poor adherence, which is difficult to achieve without a 1 to 1 nurse-to-patient ratio and within the intensive care setting. Secondly, the main outcome of this study was assessed by postal questionnaire and telephone interviews for postal non-responders – this method is now replaced with a more preferred method of remote multiple-rater video-recorded interviews or in-person interviews and examinations. Finally, perhaps low-dose oxygen supplementation may not have been sufficient to prevent severe desaturations. Overall, this study provides evidence suggesting among patients who have had an acute stroke, that routine supplemental oxygen for 72 hours post-event did not reduce death or disability at 3 months compared to patients who did not receive routine oxygen.

Click to read the study, published in JAMA

Relevant Reading: Monitoring after the acute stage of stroke: a prospective study.

RELATED REPORTS

CYP2C19 loss-of-function carriers have modest benefit from ticagrelor and aspirin following cerebrovascular event: CHANCE-2 Trial

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

Endovascular therapy for large ischemic strokes provides better functional outcomes

In-Depth [randomized control study]: This randomized clinical trial studied adults with a clinical diagnosis of acute stroke within 1 day of hospital admission across 136 hospitals in the UK. Patients were randomized into the following groups: 1) supplemental oxygen continuously for 72 hours (continuous group) 2) nocturnal oxygen (nocturnal group) 3) no routine oxygen, with oxygen only provided when desaturation is identified (control). Patients in the continuous and nocturnal group were given 3L/min of oxygen via nasal prong if their saturations were below 92%, and 2L/min if they were above 92%. The primary endpoint was the report of death or disability via the modified Rankin Scale (mRS) three months post-stroke, either via postal questionnaire or telephone interview for non-responders. The study found that persons who received supplemental oxygen in both the continuous and nocturnal group did not experience decreased rates of death or disability at 3 months compared to the control group. There were also no significant differences in the proportion of reported adverse events between treatment groups and control..

Of 8003 persons who were included in the study, 2668 were randomized into the continuous group, 2667 into the nocturnal group, and 2668 into the control group. The number of patients that remained in the study at three months were 2576 in the continuous group, 2576 in the nocturnal group, and 2567 in the control group. The unadjusted mRS odds ratio for a better outcome (lower mRS) was 0.97 (95%CI, 0.89 to 1.05; p = 0.47) for combined oxygen (continuous and nocturnal) vs control, and 1.03 (95%CI, 0.93 to 1.13; p = 0.61) for continuous oxygen vs nocturnal oxygen. Neurological impairment at 1 week improved from baseline to the same degree in all 3 groups with median NIHSS scores of 2 (IQR, 1 to 6) by 1 week. Mortality was similar in the oxygen (both treatment groups combined) and control groups (HR, 0.97 [99%CI, 0.78 to 1.21]; p = 0.75), and for continuous oxygen vs nocturnal oxygen (HR, 1.15 [99%CI, 0.90 to 1.48]; p = 0.15).

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ischemic strokeoxygenoxygen therapy
Previous Post

Mortality rates in the US from respiratory diseases increased from 1980 to 2014

Next Post

Participation in nutritional assistance program linked to reduced healthcare expenditures

RelatedReports

Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Chronic Disease

CYP2C19 loss-of-function carriers have modest benefit from ticagrelor and aspirin following cerebrovascular event: CHANCE-2 Trial

June 23, 2022
FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Patient Basics: Stroke Overview
Emergency

Endovascular therapy for large ischemic strokes provides better functional outcomes

April 22, 2022
Combined MRI and NIH stroke scores may predict stroke prognosis
Emergency

Large vessel occlusion stroke is associated with poor prognosis in children

March 29, 2022
Next Post
Higher pre-pregnancy BMI linked to adverse adolescent cardio-metabolic profile

Participation in nutritional assistance program linked to reduced healthcare expenditures

PCSK9 inhibitors unlikely to be cost-effective

2 Minute Medicine Rewind September 25, 2017

AAP reaffirms support for adolescents’ rights to confidential reproductive care

Hospital visits higher among adolescents with recent justice system involvement

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
  • FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.